ArticleJournal of translational medicine2026
IMPA2 ameliorates high-fat diet-induced obesity by enhancing adaptive thermogenesis in a Ca²⁺-activated mitochondrial biogenesis pathway.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundObesity poses a significant threat to global human health. The identification of thermogenic adipocytes in humans proves that enhanced adaptive thermogenesis may help mitigate obesity. Although some evidence suggests a role for IMPA2 in cellular metabolism, its specific impact on obesity and the underlying mechanisms remain underexplored.
methodsHigh-fat-diet (HFD)-induced obese mice were employed as experimental models. Cold exposure (4 °C) or administration of the β3-adrenoceptor agonist CL316,243 was used to stimulate adipose thermogenesis. In vivo modulation of IMPA2 function was achieved through subcutaneous injection of adeno-associated virus (AAV). Body weight and energy metabolism were monitored by the CLAMS, and browning was determined. The role and mechanisms of IMPA2 in thermogenesis were examined through adenovirus (Adv) treatment, followed by in vitro and in vivo analyses.
resultsThermogenic stimulation increased IMPA2 level in murine inguinal white adipose tissue (iWAT), whereas obesity resulted in its downregulation. IMPA2 overexpression in iWAT accelerated iWAT browning and thermogenesis, conferring protection against HFD-induced obesity and metabolic disturbances. Conversely, silencing IMPA2 reduced thermogenic gene levels in iWAT and inhibited WAT browning. Mechanistically, IMPA2 elevated myo-inositol (MI), inositol-1,4,5-trisphosphate (IP3) and intracellular calcium ion (Ca²⁺) levels, which subsequently activated Ca²⁺-dependent protein kinase IIα (CamKIIα) and PGC1α axis to increase mitochondrial biogenesis and thermogenic capacity in adipocytes.
conclusionsIMPA2 plays a crucial role in adaptive thermogenesis and energy expenditure. IMPA2 improves obesity and metabolic disorders, with its thermogenic enhancement mediated by the Ca²⁺-activated mitochondrial biogenesis pathway.
Indexed as
Identifiers
42421049What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.